Trial intelligence / Profile preview

Fluticasone propionate MDI crossover study in mild to moderate persistent asthma

2012-003395-40Phase 4Completed

Sponsor
Allergan
Start
Aug 2012
Modality
Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules
Countries
1
01

Overview

A Phase 4 trial of fluticasone propionate in asthma, persistent asthma, sponsored by Allergan. Started Aug 2012; status: completed.

02

Drugs

fluticasone propionate
03

Conditions

asthmapersistent asthma

Beyond the preview

Go deeper on 2012-003395-40.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on 2012-003395-40.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call